Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-16-097908
Filing Date
2016-04-29
Accepted
2016-04-29 17:08:48
Documents
5
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A v438378_10ka.htm 10-K/A 231414
2 EXHIBIT 31.1 v438378_ex31-1.htm EX-31.1 8869
3 EXHIBIT 31.2 v438378_ex31-2.htm EX-31.2 8740
4 EXHIBIT 32.1 v438378_ex32-1.htm EX-32.1 3980
5 EXHIBIT 32.2 v438378_ex32-2.htm EX-32.2 4362
  Complete submission text file 0001144204-16-097908.txt   258482
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36602 | Film No.: 161608099
SIC: 2834 Pharmaceutical Preparations